403 related articles for article (PubMed ID: 10929704)
1. Medical management of obesity.
Berke EM; Morden NE
Am Fam Physician; 2000 Jul; 62(2):419-26. PubMed ID: 10929704
[TBL] [Abstract][Full Text] [Related]
2. [What effect does losing weight have on hypertension?].
Engeli S
MMW Fortschr Med; 2003 Jul; 145(27-28):44. PubMed ID: 14587188
[No Abstract] [Full Text] [Related]
3. Combining behavioral and pharmacological treatments for obesity.
Phelan S; Wadden TA
Obes Res; 2002 Jun; 10(6):560-74. PubMed ID: 12055334
[TBL] [Abstract][Full Text] [Related]
4. [A practicing physician's view on obesity].
Juhász A; Katona E; Csongrádi E; Paragh G
Orv Hetil; 2006 Apr; 147(13):579-90. PubMed ID: 16623440
[TBL] [Abstract][Full Text] [Related]
5. Modern medical management of obesity: the role of pharmaceutical intervention.
Aronne LJ
J Am Diet Assoc; 1998 Oct; 98(10 Suppl 2):S23-6. PubMed ID: 9787732
[TBL] [Abstract][Full Text] [Related]
6. Exploring synergies in the treatment of obesity.
Wadden TA
Postgrad Med; 2001 Jun; 109(6 Suppl):29-33. PubMed ID: 19667565
[TBL] [Abstract][Full Text] [Related]
7. Long-term pharmacotherapy for obesity.
Klein S
Obes Res; 2004 Dec; 12 Suppl():163S-6S. PubMed ID: 15687412
[TBL] [Abstract][Full Text] [Related]
8. The new role of pharmacotherapy for weight reduction in obesity.
Fernstrom MH; Fernstrom JD
Int J Clin Pract; 2002 Nov; 56(9):683-6. PubMed ID: 12469983
[TBL] [Abstract][Full Text] [Related]
9. Effects of sibutramine plus orlistat in obese women following 1 year of treatment by sibutramine alone: a placebo-controlled trial.
Wadden TA; Berkowitz RI; Womble LG; Sarwer DB; Arnold ME; Steinberg CM
Obes Res; 2000 Sep; 8(6):431-7. PubMed ID: 11011909
[TBL] [Abstract][Full Text] [Related]
10. [How safe are the new obesity drugs? Indications and contraindications of orlistat and sibutramine].
Richter WO
MMW Fortschr Med; 1999 Dec; 141(49-50):32-6. PubMed ID: 10726144
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological management of obesity.
Hanif MW; Kumar S
Expert Opin Pharmacother; 2002 Dec; 3(12):1711-8. PubMed ID: 12472368
[TBL] [Abstract][Full Text] [Related]
12. Emerging strategies for weight management. Summary.
Hansen BC
Postgrad Med; 2001 Jun; 109(6 Suppl):40-4. PubMed ID: 19667567
[TBL] [Abstract][Full Text] [Related]
13. Pharmacologic agents for the treatment of obesity.
Mathys M
Clin Geriatr Med; 2005 Nov; 21(4):735-46, vii. PubMed ID: 16182086
[TBL] [Abstract][Full Text] [Related]
14. [Anti-obesity drugs: sibutramine and orlistat].
Sempere I Verdú E; Palop Larrea V; Hidalgo Mora JJ; Martínez-Mir I
Med Clin (Barc); 2002 Mar; 118(11):437; author reply 437-8. PubMed ID: 11943108
[No Abstract] [Full Text] [Related]
15. The effects of sibutramine and orlistat on the ultrasonographic findings, insulin resistance and liver enzyme levels in obese patients with non-alcoholic steatohepatitis.
Sabuncu T; Nazligul Y; Karaoglanoglu M; Ucar E; Kilic FB
Rom J Gastroenterol; 2003 Sep; 12(3):189-92. PubMed ID: 14502318
[TBL] [Abstract][Full Text] [Related]
16. [Overweight patient has tried many times to lose weight. What helps against stubborn fat padding?].
Wirth A
MMW Fortschr Med; 2003 Mar; 145(10):16. PubMed ID: 12688021
[No Abstract] [Full Text] [Related]
17. [Obesity in adults].
Suter PM; Kolyvanos NU; Käser L; Vetter W
Praxis (Bern 1994); 2007 Oct; 96(42):1617-24; quiz 1625-6. PubMed ID: 17974121
[No Abstract] [Full Text] [Related]
18. Who will lose weight on sibutramine and orlistat? Psychological correlates for treatment success.
Elfhag K; Finer N; Rössner S
Diabetes Obes Metab; 2008 Jun; 10(6):498-505. PubMed ID: 17593239
[TBL] [Abstract][Full Text] [Related]
19. Safe and effective management of the obese patient.
Collazo-Clavell ML
Mayo Clin Proc; 1999 Dec; 74(12):1255-9; quiz 1259-60. PubMed ID: 10593355
[TBL] [Abstract][Full Text] [Related]
20. Orlistat (Xenical) in the management of obesity.
Cheah JS
Ann Acad Med Singap; 2000 Jul; 29(4):419-20. PubMed ID: 11056767
[No Abstract] [Full Text] [Related]
[Next] [New Search]
